quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:19:59·21d
SECFiling
PharmaCyte Biotech Inc. logo

PharmaCyte Biotech Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

PMCB· PharmaCyte Biotech Inc.
Health Care
Original source

Companies

  • PMCB
    PharmaCyte Biotech Inc.
    Health Care

Recent analyst ratings

  • Nov 8UpdateHC Wainwright & Co.-

Related

  • INSIDER21d
    SEC Form 4 filed by Walker Wayne Remell
  • INSIDER21d
    SEC Form 4 filed by Weinstein Robert
  • INSIDER21d
    SEC Form 4 filed by Schechter Jonathan
  • INSIDER21d
    SEC Form 4 filed by Abecassis Michael M
  • SEC37d
    SEC Form 10-Q filed by PharmaCyte Biotech Inc.
  • SEC46d
    SEC Form DEF 14A filed by PharmaCyte Biotech Inc.
  • SEC55d
    SEC Form PRE 14A filed by PharmaCyte Biotech Inc.
  • INSIDER106d
    CEO and President Silverman Joshua bought $80,476 worth of shares (100,000 units at $0.80), increasing direct ownership by 32% to 416,250 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022